Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.930
-0.020 (-1.03%)
Aug 6, 2026, 12:47 PM EDT - Market open
Allogene Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | 0.02 | 0.1 | 0.16 | 114.09 | |
Revenue Growth | - | - | -76.84% | -39.10% | -99.86% | - |
Gross Profit | - | - | 0.02 | 0.1 | 0.16 | 114.09 |
Selling, General & Admin | 55.88 | 56.78 | 65.21 | 71.67 | 79.31 | 74.11 |
Research & Development | 131.96 | 150.15 | 192.3 | 242.91 | 256.39 | 220.18 |
Other Operating Expenses | - | 2.38 | 15.72 | 13.25 | - | - |
Total Operating Expenses | 187.83 | 209.32 | 273.22 | 327.83 | 335.69 | 294.28 |
Operating Income | -190.22 | -209.32 | -273.2 | -327.74 | -335.54 | -180.19 |
Interest Income | 17.35 | 19.29 | 20.15 | 18.31 | 4.57 | 1.71 |
Interest Expense | -1.23 | -1.08 | -0.18 | - | - | - |
Other Non-Operating Income (Expense) | 0.34 | 0.22 | -3.92 | -17.84 | -9.44 | -3.57 |
Total Non-Operating Income (Expense) | 16.46 | 18.43 | 16.05 | 0.47 | -4.88 | -1.86 |
Pretax Income | -173.76 | -190.89 | -257.15 | -327.27 | -340.41 | -182.05 |
Provision for Income Taxes | - | - | 0.44 | - | - | - |
Net Income | -173.76 | -190.89 | -257.59 | -327.27 | -340.41 | -182.05 |
Net Income to Common | -173.76 | -190.89 | -257.59 | -327.27 | -340.41 | -182.05 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 227 | 221 | 195 | 157 | 143 | 136 |
Shares Outstanding (Diluted) | 227 | 221 | 195 | 157 | 143 | 136 |
Shares Change | 9.96% | 13.25% | 24.14% | 9.63% | 5.39% | 12.84% |
EPS (Basic) | -0.77 | -0.87 | -1.32 | -2.09 | -2.38 | -1.34 |
EPS (Diluted) | -0.77 | -0.87 | -1.32 | -2.09 | -2.38 | -1.34 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -109.53 | -149.63 | -200.99 | -239.25 | -225.71 | -206.26 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.48 | -0.68 | -1.03 | -1.52 | -1.58 | -1.52 |
Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | - | - | -1241810.00% | -344986.00% | -215087.00% | -157.94% |
Profit Margin | - | - | -1170860.00% | -344489.00% | -218214.00% | -159.57% |
FCF Margin | - | - | -913609.00% | -251841.00% | -144686.00% | -180.79% |
EBITDA | -178.09 | -196.96 | -259.56 | -313.54 | -321.24 | -169.74 |
EBITDA Margin | - | - | -1179820.00% | -330040.00% | -205924.00% | -148.78% |
EBIT | -190.22 | -209.32 | -273.2 | -327.74 | -335.54 | -180.19 |
EBIT Margin | - | - | -1241810.00% | -344986.00% | -215087.00% | -157.94% |
Effective Tax Rate | - | 0.00% | -0.17% | 0.00% | 0.00% | 0.00% |